Abstract
Introduction
cardiac myocytes. Two n23 PUFA, eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, have been Dietary n23 polyunsaturated fatty acids (v-3 or n23 shown to decrease electrical excitability and automaticity PUFA, fish oils) decrease the risk of sudden cardiac death in cultured neonatal rat myocytes [12, 13] . Antiarrhythmic 1 [1] [2] [3] [4] , which may reflect antiarrhythmic efficacy. Animals effects of n23 PUFA may be related to inhibition of Na 21 administered n23 PUFA exhibit reduction in heart rate [16, 37] and / or Ca currents [10, 11, [14] [15] [16] . 21 and ischemia-induced ventricular fibrillation [5, 6] . n23 DHA decreased peak L-type Ca current (I ) in rat Ca-L PUFA also inhibit arrhythmic activity triggered by bventricular myocytes [15, 16] , without significant changes adrenergic agonists [7] , lysophospholipids [8] , ouabain in the voltage-dependence of activation or inactivation 21 [9, 10] and elevated extracellular Ca [11] in isolated [15] . Inhibition of I by n23 PUFA would be expected to inhibit contractions triggered by influx of Ca and thereby decrease contractility. However, protective effects Abbreviations: CICR calcium-induced calcium release; DHA, 21 of n23 PUFA in rat myocytes were not accompanied by docosahexaenoic acid; EPA, eicosapentaenoic acid; I , L-type Ca Ca-L current; PUFA, polyunsaturated fatty acid(s); SR, sarcoplasmic reticulum; depression of contraction [7, 8, 10] . The mechanism by TTX, tetrodotoxin; V , half maximum steady-state inactivation voltage; E-mail address: gregory.ferrier@dal.ca (G.R. Ferrier) . Time for primary review 34 days. 21 21 considered only within the context of Ca - 
I
, binds to Ca release channels (ryanodine receptors) glucose (pH 7.4 with NaOH) [19, 20] . Na current was Ca-L in the sarcoplasmic reticulum (SR) and cause them to blocked with lidocaine (200 mM) and / or tetrodotoxin 1 21 21 (TTX, 50 mM). The Na concentration also was reduced release SR Ca . The amount of Ca released by CICR is 1 to facilitate block of Na current. A stock solution of graded by the amplitude of I [17] . Therefore, block of Ca-L DHA (100 mM, in ethanol) was stored under N at I by DHA should inhibit CICR. 2 
Ca-L
220 8C and diluted to 10 mM in buffer immediately prior Recent evidence indicates that cardiac excitation-conto use [16, 17] . The final concentration of ethanol traction (EC) coupling also can be mediated by a second (,0.05%) did not cause detectable changes in contractions mechanism which is not graded by I [18] [19] [20] [21] [22] . The Ca-L  21  21  21  21 or currents. Application of Cd and Ni to block Ca amplitudes of contractions and Ca transients initiated by currents was accomplished at 37 8C with a rapid solution this mechanism show a sigmoidal dependence on memchanger. Blockers were applied after conditioning pulses, brane potential, rather than the bell-shaped proportionality but 3 s in advance of test steps. Controls utilized the same to I exhibited by CICR [18, 19, 22] . Because this mg kg ). Hearts were removed and perfused through the 21 21 aorta with Ca -and Mg -free perfusate. Collagenase 2.3. Materials (0.5 mg / ml, Worthington I (202 U / mg) and protease (0.1 mg / ml; Sigma type XIV (5.2 U / mg) were then included in DHA was obtained from Nu-Chek-Prep (Elysian, MN, the perfusate for approximately 8 min. Subsequently the USA) and was checked for purity and quantitated by GLC ventricles were minced and cells released by gentle following conversion to its methyl ester [27] . TTX was 1 agitation in a K -and substrate-enriched solution. purchased from Alomone Labs (Jerusalem, Israel) LidoMyocytes were placed in a chamber on an inverted caine HCl, tetracaine and CdCl were purchased from 3. Results
DHA selectively inhibits CICR
We first compared effects of DHA on VSRM-and CICR-induced contractions initiated by sequential activation steps to 240 and 0 mV from a V of 265 mV. In the PC absence of DHA (Fig. 1A) , the step to 240 mV initiated a VSRM contraction with little inward current. The step to 0 21 mV elicited a CICR contraction and a large inward Ca current, previously identified as I [18, 19, 23, 24, 26] . Ca-L When myocytes were superfused with 10 mM DHA effects developed gradually. After 20 min, a large VSRM contraction still occurred with the step to 240 mV, but CICR contractions and I initiated by the step to 0 mV were Ca-L virtually abolished (Fig. 1B ). Fig. 2 shows that DHA did not significantly alter mean amplitudes of VSRM contractions, but dramatically reduced amplitudes of CICR-induced contractions by 93% (P,0.001) (Fig. 2 , top). Mean data showed that DHA slightly but significantly (P,0.01) increased the small inward current observed with the step to 240 mV ( Fig. 2 , bottom). In contrast, the magnitude of peak I elicited by the step to 0 mV was strongly tions. DHA did not significantly affect VSRM contractions initiated by the step to 240 mV, but a small increase in inward current was observed. In contrast, DHA markedly inhibited both CICR contraction and inward current elicited by steps to 0 mV. n524, control, n518, DHA; *P,0.05, **P,0.01.
inhibited (approximately 85%) by DHA (P,0.001). Thus, our observations demonstrate that DHA selectively inhibits CICR, with little if any effect on VSRM contractions.
Effects of DHA on contraction-voltage (CV) and current-voltage (IV) relations
To further investigate effects of DHA, we determined CV relations with activation steps to different membrane potentials. Effects of DHA on CICR in the absence of the VSRM were evaluated with test steps from a V of 240 PC mV to inactivate the VSRM [19] (Fig. 3A) . Representative recordings of contractions and currents in the absence of DHA are shown in Fig. 3B . A step from 240 to 0 mV triggered inward I and a large contraction. When the Ca-L test step was changed to 180 mV, inward current was no in amplitude with DHA (Fig. 3C ). Mean CV and IV relations are plotted in Fig. 4A and B, respectively. Before exposure to DHA, the CV curve was bell-shaped and closely reflected the profile of the IV relation for I , as the myocyte had been exposed to DHA. When the V was Ca-L PC expected for CICR [17] . Exposure to 10 mM DHA, 270 mV, large, phasic contractions were elicited with all strongly inhibited I and abolished CICR contractions at three test steps. I was clearly inhibited on the step to 0
Ca-L Ca-L all activation steps (Fig. 4) . mV, and remained absent at 180 mV. In this example, a IV and CV curves also were determined with a V of small inward current was observed with the step to 240 PC 270 mV (Fig. 5A ). With this V , both CICR and the mV.
PC VSRM are available and may contribute to contraction Mean CV and IV relationships determined with a V of PC [18, 19, 23, 24, 26] . Fig. 5B shows representative recordings 270 mV are illustrated in Fig. 6 . In the absence of DHA before exposure to DHA. When the V was 270 mV, a the CV relationship was sigmoidal, as expected when the PC phasic contraction was initiated by the step to 240 mV VSRM is available for activation [18, 19, 23, 24, 26] . Thus, although little or no inward current was evident. With a contraction no longer reflected the bell-shaped IV relation. step to 0 mV, a larger contraction and inward I were When DHA was included in the superfusate, the CV Ca-L elicited. A large phasic contraction also was elicited at relation remained sigmoidal. Contractions exhibited a 180 mV, although inward current was no longer elicited at threshold near 260 mV, reached maximum amplitude near this potential. Fig. 5C shows corresponding records after 220 mV, and remained maximal up to 180 mV. The DHA inhibited virtually all inward current elicited from Inward current approached 0 nA near 140 mV. Thus, a V of 240 mV, but current was still observed with a V PC PC contraction clearly was not proportional to the current of 270 mV (Figs. 4 and 6 ). The protocols used are the 21 remaining in the presence of DHA. In these experiments, same as those for separating L-and T-type Ca currents. mean current decreased relative to control at all potentials.
Thus it is possible that the current remaining with DHA is 21 This differs from Fig. 2 where an increase was observed at T-type Ca current [28] . Indeed, with DHA, the IV 240 mV. This may reflect differences in protocols. CV and relation shifted negatively, as expected if the current remaining was T-current. Cd almost completely inhibited this inward current. 21 The sensitivity of current to Cd suggests that current remaining in the presence of DHA is L-type current. The negative IV relation in the presence of DHA might be caused by inward Na-Ca exchange current, which would be greatest at negative potentials. To eliminate this possibility we evaluated effects of DHA with patch pipettes containing 5-10 mM EGTA, to buffer changes in free 21 intracellular Ca caused by SR release. Under these conditions contractions were absent. Fig. 8A shows records of currents elicited with the two-step protocol with 2 mM 21 (left) and 0 mM extracellular Ca (right). These records also are shown superimposed to demonstrate that signifi-21 cant inward Ca current was not elicited by a step 240 mV, and that I decayed completely within the second Ca-L 200 ms step to 0 mV. Thus, measurement of peak inward current relative to net current at the end of the step 21 accurately represents inward Ca current at both potentials. Fig. 8B shows representative recordings used to determine IV relations. DHA strongly inhibited inward Ca-L current elicited by a step from 240 to 0 mV (left). However, with a step from 270 to 0 mV, a larger current remained in the presence of DHA (right). Fig. 8C shows mean IV relations. DHA almost completely blocked inward 21 Ca current when steps were initiated from 240 mV. However, when steps were made from 270 mV inward current was blocked less. DHA reduced mean inward current at 0 mV to 0.2060.07 nA (13.4%) with steps from 21 21 Fig . 7 . Effects of Ni and Cd on IV relations in the presence of DHA. made from 270 mV (P,0.05). The negative shift of IV mM) inhibited current approximately 50%, whereas Cd (100 mM) almost completely inhibited inward current. n55 for each group.
relations by DHA was virtually eliminated. Thus, effects of 
. contractions were independent of inward current, even Ca-L To evaluate the role of residual I in initiation of with test steps to potentials at which current could be contraction, we also examined the effects of Cd on elicited in the presence of DHA. contraction amplitude. Because repeated applications of 21 Cd gradually caused spontaneous contractions, complete 3.4. Steady-state inactivation of contractions in the CV relations were not generated. Rather, effects were presence of DHA determined only for steps that elicited near maximal current. A representative example is shown in Fig. 9 . In the Since contractions in the presence of DHA were not presence of 10 mM DHA, a step to 210 mV elicited an proportional to I and could be elicited when current inward current plus a contraction (Fig. 9A) . Rapid applicaCa-L 21 21 tion of 100 mM Cd blocked the current; however, the was blocked by Cd , it is likely that these contractions amplitude of the contraction was not affected (Fig. 9B) .
were initiated by the VSRM [18, 19, 23, 26] . If this is correct, these contractions should show steady-state inactivation characteristic of the VSRM [19, 23] . Steady-state inactivation curves were determined before and after exposure to 10 mM DHA, with the protocol illustrated in Fig. 11B were normalized to the maximum contraction amplitude for each experiment. These data were fit to Boltzmann functions represented by the solid lines. In the presence of DHA, the half-inactivation voltage (V ) was slightly more negative h (252.1 mV) than that for control myocytes before exposure to DHA (246.0 mV). However, V after exposure to h DHA was very similar to values previously reported for the VSRM [19, 23] , and to the value observed for the VSRM in the absence of DHA in the present study.
Discussion
Our study demonstrates for the first time that a major n23 PUFA, DHA, inhibits I , while preserving contrac- Ca-L tion in the same myocytes. Our study explains these apparently contradictory observations by demonstrating that DHA inhibits CICR by inhibiting its primary trigger, I , but does not inhibit the VSRM. Thus, DHA inhibits Ca-L only one of two mechanisms for cardiac EC coupling.
Mechanism of EC-coupling in the presence of DHA
Earlier studies reported that inhibition of I by n23 PUFA also decreased myocyte shortening [11] and Ca transients [15] . These studies were conducted at low temperatures (22-32 8C) and with cells dialyzed with patch pipette solutions containing neither cAMP nor calmodulin. Either of these conditions would inhibit the VSRM [22, 26] . We also found that DHA abolished contractions along with I when the VSRM was unavailCa-L able. However, contractions persisted when the V was PC 270 mV and both the VSRM and CICR were available. This can be explained by differential effects of DHA on the VSRM and CICR, as shown in experiments with sequential activation steps to 240 and 0 mV. DHA clearly from a V of 270 mV. These contractions exhibited a mV. It is possible that DHA promoted exchange current by PC 1 sigmoidal CV relation, in which amplitudes of contraction providing additional block of Na current [16, 37] and 1 were independent of magnitude of inward current, which is reducing intracellular Na levels. This effect of DHA typical of the VSRM [18, 19, 22] or to reverse mode Na -Ca exchange triggered by Na function. influx. It also is unlikely that these contractions were 1 21 caused by reverse mode Na -Ca exchange, because they exhibited steady-state inactivation and could not be
